Gainers
Jasper Therapeutics, Inc. (NASDAQ: JSPR) shares surged 105.1% to close at $14.79 on Wednesday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $21 price target.
Gainers
Jasper Therapeutics, Inc. (NASDAQ: JSPR) shares jumped 113% to $15.36 after Oppenheimer initiated coverage on the stock with an Outperform rating and a $21 price target.
Toward the end of trading Tuesday, the Dow traded down 0.13% to 34,450.01 while the NASDAQ rose 0.01% to 14,486.37. The S&P also fell, dropping 0.10% to 4,356.92.
Midway through trading Tuesday, the Dow traded down 0.18% to 34,434.80 while the NASDAQ fell 0.14% to 14,466.15. The S&P also fell, dropping 0.19% to 4,352.77.
Following the market opening Tuesday, the Dow traded up 0.20% to 34,564.47 while the NASDAQ rose 0.06% to 14,494.82. The S&P also rose, gaining 0.12% to 4,366.61.